Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
MVP-AF: Memantine vs propafenone in paroxysmal atrial fibrillation
ChiCTR2300068027Phase 4Not yet recruiting
- Sponsor
- Shanghai East Hospital
- Start
- Feb 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of memantine in Atrial fibrillation (AFib) (2 arms), sponsored by Shanghai East Hospital. Primary endpoint: Time to first recurrence of atrial fibrillation. Planned start Feb 2023; status: not yet recruiting.
02
Drugs
memantine
03
Conditions
Atrial fibrillation (AFib)
Beyond the preview
Go deeper on ChiCTR2300068027.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2300068027.